Press Releases -> Pharmaceuticals & Biotech Syndicate content

Oct 11, 2019
  • The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB
  • CMAB will provide full development and manufacturing services for BJ Bioscience's BJ-005 bi-functional antibody
  • BJ-005 is planned to enter...
  • Sep 24, 2019

    HONG KONG, Sept. 24, 2019 -- The Hong Kong Polytechnic University (PolyU) has developed a new class of antibiotic drug candidates which has high potential to be developed into a new generation of antibiotics fighting against multi-drug resistant superbugs including methicillin-resistant Staphylococcus aureus (MRSA...

    Sep 10, 2019

    BEIJING--(BUSINESS WIRE)--Herbalife Nutrition (NYSE: HLF), a premier global nutrition company, today announced a donation of $1.5 million from the China Growth and Impact Investment Program to the Beijing Sport University Education Foundation to further nutrition research and assist in the development of winter...

    Sep 03, 2019

    ‘Latest advances in Cosmetic Dermatology, Plastic Surgery, Facial Aesthetics and Anti-Aging’ to be highlighted

    Aug 28, 2019

    First and only Adenosine A2A receptor antagonist for use in Parkinson’s Disease in the U.S.

    TOKYO--(BUSINESS WIRE)--Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for NOURIANZ™ (istradefylline) for use as adjunctive...

    Aug 28, 2019

    HUDSON, Wis.--(BUSINESS WIRE)--Phillips-Medisize, a Molex company, announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference, organized by the China National Pharmaceutical Packaging Association (CNPAA) and to be held from September 1 to 3 in Suzhou Industrial Park. As an...

    Aug 25, 2019

    An international team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has grown ‘miniature kidneys’ in the laboratory that could be used to better understand how kidney diseases develop in individual patients.

    The mini kidneys, known as kidney organoids, were grown outside...

    Aug 14, 2019

    Proceeds to Support Development of Clinical Parkinson’s and Alzheimer’s Candidates and Preclinical Fibrosis Candidate

    Financing Led by Octave Life Sciences, joined by Smilegate Investment and other Series A Investors

    Aug 02, 2019
  • Channelling Supply Chains of Medical Institutes, High-Tech, Pharma and Medical Devices
  • Getting Ahead for a $2,660 bn Healthcare Sector Booming in Asia Pacific Regions

    TAIPEI --( ASIA TODAY )-- Starting on December 5 through 7 of 2019, The Healthcare+ Expo Taiwan, a powerhouse aligning advanced...

  • Aug 02, 2019

    Rangsit University, a private university in Pathum Thani, Thailand which is one of the few educational institutions licensed by the Thai government to research on the medical use of marijuana and develop respective products, is positive on the development of marihuana as a business case in the country according to...

    Jul 31, 2019

    HYDERABAD, India--(BUSINESS WIRE)--GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a strategic collaboration in...

    Jul 31, 2019

    INCHEON, South Korea, July 31, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals. UCB's anti-tau candidate is currently...

    Jul 24, 2019

    SINGAPORE, July 24, 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc. ("Global BioLife").

    Jul 23, 2019

    Strategic Healthcare Consulting subsidiary will support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong presence; biopharma and medtech veteran Gary Cheng to lead local team

    Jul 14, 2019

    Kenneth Lee envisions a 'biofarming' future for Hong Kong

    CUHK embryologist Kenneth Lee is working to manufacture living tissue in the lab. That shows great promise for developing human organ patches that could be used to repair the body.

    There’s another important use for manufactured tissue: we can...

    Jul 11, 2019

    SINGAPORE, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in...

    Jul 10, 2019

    TOKYO--(BUSINESS WIRE)--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received self-affirmed GRAS (Generally Recognized as Safe) for infant formulas, in honor of its 50th anniversary.

    ...
    Jul 07, 2019

    Strives to Change the Cancer Treatment Model in Hong Kong
    Ready to Tap Tremendous Opportunities in Greater Bay Are

    Jun 17, 2019

    Beijing, 17 June 2019 --( ASIA TODAY )-- Reed Sinopharm Exhibitions (RSE) is delighted to share key highlights from its Personal Care and Homecare Ingredients (PCHi) 2019 post-show report.

    Jun 03, 2019

    FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ -- As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee and the People's...

    Jun 03, 2019

    SEONGNAM-SI, South Korea--(BUSINESS WIRE)--Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial for telacebec (Q203), a first-in-class, orally-available antibiotic for the treatment of tuberculosis (TB). Telacebec is a selective inhibitor with high...

    May 30, 2019

    Promoting precision medicine business with in-house assets and collaboration with external venture partner